IL-1β modulates inflammatory response of human bone marrow-derived MSCs and neutrophil recruitment in vitro via

Nour Hassaan1, Tobias Schmidt2,3,4, Zackarias Söderlund1

  • 1Department of Experimental Medical Science, Faculty of Medicine, Lund University, BMC C12, 221 84, Lund, Sweden.

Abstract

Insights

Interleukin-1β (IL-1β) enhances mesenchymal stromal cell (MSC) function, increasing neutrophil recruitment. Inhibiting the NF-kB pathway reduces this effect, offering insights into MSC-based therapy for acute respiratory distress syndrome (ARDS).

Area of Science:

  • Immunology
  • Cell Biology
  • Regenerative Medicine

Background:

  • Mesenchymal stromal cells (MSCs) show variable outcomes in acute respiratory distress syndrome (ARDS) therapy, influenced by host factors like Interleukin-1β (IL-1β).
  • IL-1β is implicated in ARDS development and can predict MSC activation.
  • Mechanisms of IL-1β's impact on MSC function and immune cell interactions are unclear.

Purpose of the Study:

  • To investigate how IL-1β alters MSC function.
  • To specifically examine the effect of IL-1β on MSC-neutrophil interactions.

Main Methods:

  • Human bone marrow-derived MSCs were treated with IL-1β (20 ng/ml) for 1 or 24 hours.
  • Bulk RNA sequencing and secretome analysis were performed on treated MSCs.
  • Neutrophil recruitment capacity was assessed using transwell assays, with and without NF-kB inhibition.

Main Results:

  • IL-1β exposure upregulated genes related to immune response and neutrophil recruitment in MSCs.
  • MSCs treated with IL-1β demonstrated significantly enhanced neutrophil recruitment capacity.
  • Inhibition of the NF-kB pathway reduced MSC-mediated neutrophil recruitment to baseline levels.

Conclusions:

  • IL-1β modulates MSC function, enhancing their capacity to recruit neutrophils via the NF-kB pathway.
  • These findings provide mechanistic insights into MSC-immune cell interactions within the host microenvironment.
  • Understanding these interactions is crucial for optimizing MSC-based therapies for ARDS.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K